Sabby Management’s Acutus Medical Inc AFIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-93,000
Closed -$104K 145
2022
Q2
$104K Sell
93,000
-925,950
-91% -$795K 0.07% 81
2022
Q1
$1.42M Buy
1,018,950
+273,350
+37% +$584K 0.21% 32
2021
Q4
$2.54M Buy
745,600
+625,845
+523% +$3.52M 0.37% 43
2021
Q3
$1.06M Buy
119,755
+16,655
+16% +$219K 0.14% 83
2021
Q2
$1.75M Sell
103,100
-29,422
-22% -$430K 0.25% 63
2021
Q1
$1.77M Buy
132,522
+55,022
+71% +$1.24M 0.34% 56
2020
Q4
$2.23M Buy
77,500
+27,844
+56% +$754K 0.43% 35
2020
Q3
$1.48M Buy
+49,656
New +$1.51M 0.22% 54

Other funds holding AFIB

Sabby Management's AFIB Position: Q3 2022 in Review

Sabby Management sold out of Acutus Medical Inc (AFIB) in Q3 2022, closing a stake of 93,000 shares — an estimated $104K sold.

Sabby Management first reported a position in AFIB in Q3 2020 and held it in 8 quarters. The position peaked at $2.54M in Q4 2021. 37 funds tracked by Wall St. Rank hold AFIB as of Q3 2022.

  • Sabby Management reported no remaining Acutus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Sabby Management sold 93,000 Acutus Medical Inc shares in Q3 2022, an estimated $104K.
  • Sabby Management first reported a position in Acutus Medical Inc in Q3 2020 and held it in 8 quarters.
  • Sabby Management's Acutus Medical Inc position peaked at $2.54M in Q4 2021.
  • 37 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q3 2022.

Based on Sabby Management's 13F filing for Q3 2022, filed 14 Nov 2022.